Clinical Trials Browser

Not yet recruiting × Interventional × Hodgkin Disease × Clear all

NCT07164469 2026-06-05

Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

Phase 2 Not yet recruiting

Hodgkin Disease

NCT07021989 2026-06-04

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Not yet recruiting

Hodgkin Disease

NCT07551583 2026-05-20

Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

Phase 2 Not yet recruiting

Hodgkin Disease

NCT07451054 2026-05-14

CD45BE-HSPC + CART-45 Cells

Phase 1 Not yet recruiting

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT07444632 2026-05-08

Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies

Phase 1 Not yet recruiting

Hodgkin Disease

NCT07576725 2026-05-08

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Phase 2 Not yet recruiting

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Hodgkin Disease, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Sarcoma, Kaposi, Colorectal Neoplasms, Carcinoma, Merkel Cell

NCT07514819 2026-04-23

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

Phase NA Not yet recruiting

LymphoidSarcoma

Bone Neoplasms, Hodgkin Disease, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT07256158 2025-12-09

FIL_PRIORITY

Phase 3 Not yet recruiting

Hodgkin Disease

NCT06919679 2025-04-09

BASTION

Phase 2 Not yet recruiting

HIV Seropositivity, Hodgkin Disease

NCT06045195 2025-04-06

Pembro-FLASH

Phase 2 Not yet recruiting

Hodgkin Disease

NCT06761911 2025-01-07

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

Phase 4 Not yet recruiting

Hodgkin Disease, Recurrence

NCT06684509 2024-11-12

Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia

Phase 1/2 Not yet recruiting

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Cardiotoxicity

NCT06116929 2024-02-28

FunC-AHOD

Phase NA Not yet recruiting

Hodgkin Disease

NCT05627115 2023-11-29

RATiFY

Phase 2 Not yet recruiting

Hodgkin Disease